Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 28, 2020 08:00 ET | Source: Starton Therapeutics, Inc.

Starton Therapeutics to Present at the LifeSci Partners Summer Symposium

NEW YORK, July 28, 2020 (GLOBE NEWSWIRE) -- Starton Therapeutics Inc. (“Starton” or the “Company”), a biotechnology company focused on transforming standard of care therapeutics, announced today...
April 30, 2020 07:00 ET | Source: Starton Therapeutics, Inc.

Starton Therapeutics Files PCT and US Patent Application for Continuous Delivery of Lenalidomide and Class of Immunomodulatory Agents

NEW YORK, April 30, 2020 (GLOBE NEWSWIRE) -- Starton Therapeutics Inc. (“Starton” or the “Company”), a biotechnology company focused on transforming standard of care therapeutics, today announced...
December 27, 2019 09:00 ET | Source: Starton Therapeutics, Inc.

Starton Successfully Completes Proof of Concept Study for Transdermal Lenalidomide

NEW YORK, Dec. 27, 2019 (GLOBE NEWSWIRE) -- Starton Therapeutics Inc. (“Starton” or the “Company”), a biotechnology company focused on transforming standard of care therapeutics, today announced the...
December 26, 2019 16:30 ET | Source: Starton Therapeutics, Inc.

Starton Therapeutics: Announcing Name Change for ChemioCare Inc

NEW YORK, Dec. 26, 2019 (GLOBE NEWSWIRE) -- ChemioCare USA Inc. (“ChemioCare” or the “Company”), a biotechnology company focused on transforming standard of care therapeutics, today announced it has...
December 18, 2019 16:30 ET | Source: ChemioCare

ChemioCare Completes Successful Human Bioavailability Study for Novel 7-Day Olanzapine Transdermal Delivery System

NEW YORK, Dec. 18, 2019 (GLOBE NEWSWIRE) -- ChemioCare USA Inc. (“ChemioCare” or the “Company”), a biotechnology company focused on transforming standard of care therapeutics, today announced the...
August 29, 2019 07:40 ET | Source: ChemioCare

ChemioCare Strengthens its Proposed Slate of Directors with the Nomination of Multiple Myeloma Expert Dr. Mohamad Hussein

NEW YORK, Aug. 29, 2019 (GLOBE NEWSWIRE) -- ChemioCare USA Inc. (“ChemioCare” or the “Company”), a platform company focused on proprietary transdermal delivery, announced today the addition of Dr....
April 29, 2019 07:50 ET | Source: ChemioCare

ChemioCare Announces Appointment of Roy F. Waldron to Its Board of Directors

NEW YORK, April 29, 2019 (GLOBE NEWSWIRE) -- ChemioCare USA Inc. (“ChemioCare” or the “Company”), a platform company focused on proprietary transdermal delivery, announced today the appointment of...
April 23, 2019 08:00 ET | Source: ChemioCare

ChemioCare Announces Initiation of PETT Based (Permeation Enhanced Transdermal Technology) Lenalidomide Program

NEW YORK, April 23, 2019 (GLOBE NEWSWIRE) -- ChemioCare USA Inc. (“ChemioCare” or the “Company”), a platform company focused on proprietary transdermal delivery, announced today the Company is...
February 06, 2019 08:29 ET | Source: ChemioCare

ChemioCare Reports Positive Animal Study Results for CMIO-Ondan Patch

NEW YORK, Feb. 06, 2019 (GLOBE NEWSWIRE) -- ChemioCare USA Inc. (“ChemioCare” or the “Company”), a platform company based on proprietary transdermal delivery, today announced the minipig safety and...
January 07, 2019 10:00 ET | Source: ChemioCare

ChemioCare Strengthens Executive Management Team

NEW YORK, Jan. 07, 2019 (GLOBE NEWSWIRE) -- ChemioCare USA Inc. (“ChemioCare” or the “Company”), a Platform Company based on proprietary transdermal delivery today announced the appointment of Jamie...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right